Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model

Cancer Research

Volumn 60, Issue 10, 2000, Pages 2710-2715

  Pulaski, Beth A ^a   Terman, David S ^b   Khan, Saleem ^c   Muller, Eric ^a   Ostrand Rosenberg, Suzanne ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b Enerjen   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CANCER VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAPHYLOCOCCUS ENTEROTOXIN B;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER IMMUNIZATION; CANCER SURGERY; CANCER SURVIVAL; CELL GROWTH; CONTROLLED STUDY; FEMALE; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; VACCINE PRODUCTION;

ANIMALS; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENTEROTOXINS; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; POSTOPERATIVE CARE; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TRANSFECTION; VACCINATION;

EID: 0034657251     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Sogn, J. Tumor immunology: the glass is half full. Immunity. 9: 757-763, 1998.
2. Lattime, E. C., and Gerson, S. L. (eds.). Gene Therapy of Cancer. San Diego: Academic Press, 1998.
3. Pulaski, B. A., and Ostrand-Rosenberg, S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res., 58: 1486-1493, 1998.
4. Harris, J., Morrow, M., and Norton, L. In: V. T. Devita Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer, Principles, and Practice of Oncology, Ed. 5, pp. 1541-1616. Philadelphia: Lippmcott-Raven, 1997.
5. Ostrand-Rosenberg, S., Pulaski, B. A., Clements, V., Qi, L., Pipeling, M., and Hanyok, L. Cell-based vaccines for the stimulation of immunity to metastatic cancers. Immunol. Rev., 170: 101-115, 1999.
6. Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., and Levitsky, H. The central role of CD4+ T cells in the antitumor immune response. J. Exp. Med., 188: 2357-2368, 1998.
7. Pardoll, D., and Topalian, S. The role of CD4+ T cell responses in antitumor immunity. Curr. Opin. Immunol., 10: 588-594, 1998.
8. Ostrand-Rosenberg, S. Tumor immunotherapy: the tumor cell as an antigen presenting cell. Curr. Opin. Immunol., 6: 722-727, 1994.
9. Greenberg, P. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol., 49: 281-355, 1991.
10. Herman, A., Kappler, J. W., Marrack, P., and Pullen, A. M. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol., 9: 745-772, 1991.
11. Marrack, P., Blackman, M., Kushnir, E., and Kappler, J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med., 171: 455-464, 1990.
12. Ranelli, D., Jones, C., Johns, M., Mussey, G., and Khan, S. Molecular cloning of staphyloccocal enterotoxin B gene in Escherichia coli and Staphyloccocus aureus. Proc. Natl. Acad. Sci. USA, 82: 5850-5854, 1985.
13. Aslakson, C. J., and Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res., 52: 1399-1405, 1992.
14. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
15. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. Exp. Med., 181: 619-628, 1995.
16. Zar, J. Multisample hypotheses: the analysis of variance. In: Biostatistical Analysis, p. 162. Englewood, NJ: Prentice-Hall, 1984.
17. Dohlsten, M., Hansson, J., Ohlsson, L., Litton, M., and Kalland, T. Antibody-targeted superantigens are potent inducers of tumor-infiltrating lymphocytes in vivo. Proc. Natl. Acad. Sci. USA, 92: 9791-9795, 1995.
18. Penna, C., Dean, P. A., and Nelson, H. Antitumor x anti-CD3 bifunctional antibodies redirect T-cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases. Cancer Res., 54: 2738-2743, 1994.
19. Ochi, A., Migita, K., Xu, J., and Siminovitch, K. In vivo tumor immunotherapy by a bacterial superantigen. J. Immunol., 151: 3180-3186, 1993.
20. Dow, S., Elmslie, R., Willson, A., Roche, L., Gorman, C., and Potter, T. In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. J. Clin. Invest., 101: 2406-2414, 1998.
21. Newell, K. A., Ellenhorn, J. D. I., Bruce, D. S., and Blueslone, J. A. In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor. Proc. Natl. Acad. Sci. USA, 88: 1074-1078, 1991.
22. Inoue, M., Plautz, G., and Shu, S. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells. Cancer Res., 56: 4702-4708, 1996.
23. Shu, S., Krinock, R. A., Matsumura, T., Sussman, J. J., Fox, B. A., Chang, A. E., and Terman, D. S. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells. J. Immunol., 152: 1277-1288, 1994.
24. + T lymphocytes. J. Immunol., 160: 661-666, 1998.
25. Armstrong, T., Clements, V., Martin, B., Ting, J. P-Y., and Ostrand-Rosenberg, S. Major histocompatibility class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. Proc. Natl. Acad. Sci. USA, 120: 123-128, 1997.
26. Huang, A., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., Levitsky, H. Role of none marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Washington DC), 264: 961-965, 1995.
27. Pulaski, B. A., Yen, K-Y., Shastri, N., Maltby, K. M., Penney, D., Lord, E., and Frelinger, J. G. IL-3 enhances CTL development and class I MHC presentation of exogenous antigen by tumor-infiltrating macrophages. Proc. Natl. Acad. Sci. USA, 93: 3669-3674, 1996.
28. Matzinger, P. An innate sense of danger. Semin. Immunol., 10: 399-415, 1998.
29. Dow, S. W., and Potter, T. A. Expression of bacterial superantigen genes in mice induces localized mononuclear cell inflammatory responses. J. Clin. Invest., 99: 2616-2624, 1997.
30. Jardetzky, T., Brown, J., Gorga, J., Stern, L., Urban, R., Chi, Y., Stauffacher, C., Strominger, J , and Wiley, D. Three dimensional structure of a human class H histocompatibility molecule complexed with superantigen. Nature (Lond.), 368: 711-718, 1994.
31. Li, H., Llera, A., Tsuchiya, D., Leder, L., Ysern, X., Schlievert, P. M., Karjalainen, K., and Mariuzza, R. A. Three dimensional structure of the complex between a T cell receptor β chain and the superantigen staphylococcal enterotoxin B. Immunity, 9: 807-816, 1998.
32. Krummel, M., Sullivan, T., and Allison, J. Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int. J. Immunol., 8: 519-523, 1996.
33. Muraille, E., DeBecker, G., Bakkus, M., Thielemans, K., Urbain, J., Moser, M., and Leo, O. Co-stimulation lowers the threshold for activation of naive T cells by bacterial superantigens. Int. J. Immunol., 7: 295-304, 1995.
34. Muraille, E., DeSmedt, T., Thielemans, K., Urbain, J., Moser, M., and Leo, O. Activation of murine T cells by bacterial superantigens requires B7-mediated co-stimulation. Cell. Immunol., 162: 315-320, 1995.
35. Blankson, J., and Morse, S. The CD28/B7 pathway costimulates the response of primary murine T cells to superantigens as well as to conventional antigens. Cell. Immunol., 157: 306-312, 1994.
36. Vella, A. T., McCormack, J. E., Linsly, P. S., Kappler, J. W., and Marrack, P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity, 2: 261-270, 1995.